Laboratory Corporation of America® Holdings (LabCorp®)
(NYSE: LH) today announced that David P. King, Chairman and Chief
Executive Officer, is scheduled to speak at the Bank of America ... read more
Laboratory Corporation of America® Holdings (LabCorp®)
(NYSE: LH) today announced that its Annual Meeting of Stockholders will
be webcast live beginning May 8, 2013 at 9:00 a.m. Eastern ... read more
Laboratory Corporation of America® Holdings (LabCorp®)
(NYSE: LH) today announced results for the quarter ended March 31, 2013.
First Quarter Results
... read more
Laboratory Corporation of America® Holdings (LabCorp®)
(NYSE: LH) announced today that its Zero Coupon Convertible Subordinated
Notes due 2021 (Zero Coupon Notes) may be converted as set forth ... read more
Laboratory Corporation of America® Holdings (LabCorp®)
(NYSE: LH) announced today the availability of an expanded testing menu
to help clinicians diagnose, treat and monitor the course of
... read more
Laboratory Corporation of America® Holdings (LabCorp®)
(NYSE: LH) announced today that for the period of March 12, 2013 to
September 11, 2013, its Zero Coupon Convertible Subordinated Notes ... read more
Laboratory Corporation of America® Holdings (LabCorp®)
(NYSE:LH) today announced that Adam H. Schechter, Executive Vice
President and President, Global Human Health, Merck, has been appointed
... read more
Laboratory Corporation of America® Holdings (LabCorp®)
(NYSE: LH) today announced that David P. King, Chairman and Chief
Executive Officer, is scheduled to speak at the Barclays Capital 2013 ... read more
Laboratory Corporation of America® Holdings (LabCorp®)
(NYSE: LH) today announced the recent accreditation of its Biorepository
by the College of American Pathologists (CAP). CAP’s inaugural
... read more
Laboratory Corporation of America® Holdings (LabCorp®)
(NYSE: LH) announced today that its Zero Coupon Convertible Subordinated
Notes due 2021 (Zero Coupon Notes) may be converted as set forth ... read more